Literature DB >> 1573669

Increased effectiveness of liposome-encapsulated doxorubicin in multidrug-resistant-transgenic mice compared with free doxorubicin.

G H Mickisch1, A Rahman, I Pastan, M M Gottesman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1573669     DOI： 10.1093/jnci/84.10.804

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  9 in total

1.  Phase I study of liposomal daunorubicin in patients with acute leukemia.

Authors:  J Cortes; S O'Brien; E Estey; F Giles; M Keating; H Kantarjian
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

2.  Disposition of liposomal daunorubicin during cotreatment with cytarabine in patients with leukaemia.

Authors:  Federico Pea; Domenico Russo; Mariagrazia Michieli; Daniela Damiani; Renato Fanin; Angela Michelutti; Teresa Michelutti; Stefano Piccolrovazzi; Michele Baccarani; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 3.  P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells.

Authors:  T Licht; I Pastan; M Gottesman; F Herrmann
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

Review 4.  Chemoresistance of renal cell carcinoma: 1986-1994.

Authors:  G H Mickisch
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

Review 5.  Anthracycline antibiotics in cancer therapy. Focus on drug resistance.

Authors:  D J Booser; G N Hortobagyi
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

6.  Tissue distribution of methotrexate following administration as a solution and as a magnetic microsphere conjugate in rats bearing brain tumors.

Authors:  D Devineni; A Klein-Szanto; J M Gallo
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

7.  Phase I and pharmacologic study of liposomal daunorubicin (DaunoXome).

Authors:  P Guaglianone; K Chan; E DelaFlor-Weiss; R Hanisch; S Jeffers; D Sharma; F Muggia
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

8.  An improved method of encapsulation of doxorubicin in liposomes: pharmacological, toxicological and therapeutic evaluation.

Authors:  P C Gokhale; B Radhakrishnan; S R Husain; D R Abernethy; R Sacher; A Dritschilo; A Rahman
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

9.  Modulation of induced cytotoxicity of doxorubicin by using apoferritin and liposomal cages.

Authors:  Jaromir Gumulec; Michaela Fojtu; Martina Raudenska; Marketa Sztalmachova; Anna Skotakova; Jana Vlachova; Sylvie Skalickova; Lukas Nejdl; Pavel Kopel; Lucia Knopfova; Vojtech Adam; Rene Kizek; Marie Stiborova; Petr Babula; Michal Masarik
Journal:  Int J Mol Sci       Date:  2014-12-11       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.